Week in Review
Bind Biosciences Inc. raised $47 million in a Series D round, with Rusnano joining the syndicate.
NewLink Genetics Corp. set terms for its planned $61 million initial public offering.
Selecta Biosciences Inc. raised $47 million in a Series D round, with Rusnano joining the syndicate.
Adolor Corp. is being acquired by Cubist Pharmaceuticals Inc. for $415 million.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter